股本结构
单位：万股
| 公告日期 | 2025-11-13 | 2025-11-10 | 2025-11-10 | 2025-08-14 | 2025-08-14 | 2025-05-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 14847.90 | 11963.28 | 11512.26 | 10988.66 | 10983.21 | 10971.44 |
| 普通股本 | 14847.90 | 11963.28 | 11512.26 | 10988.66 | 10983.21 | 10971.44 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-14 | 2025-11-05 | 2025-09-30 | 2025-08-11 | 2025-06-30 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-13 | 14847.90 | 未披露 |
更多>>
1.Common Stock offered 25,096,153 shares by the company
2.The underwriter exercised the option in full to purchase 3,750,000 shares of common stock
|
2025-11-14 |
| 2025-11-10 | 11963.28 | 未披露 | 定期报告 | 2025-11-05 |
| 2025-11-10 | 11512.26 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common stock, net of issuance costs of $697
Restricted stock vested in the period
Exercise of stock options
|
2025-09-30 |
| 2025-08-14 | 10988.66 | 未披露 | 定期报告 | 2025-08-11 |
| 2025-08-14 | 10983.21 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Issuance of common stock per Employee Stock Purchase Plan purchase
|
2025-06-30 |
| 2025-05-12 | 10971.44 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Exercise of stock options
Restricted stock vested in the period
|
2025-03-31 |
| 2025-03-03 | 10970.98 | 未披露 | 定期报告 | 2025-02-26 |
| 2025-03-03 | 10938.16 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of common stock per Employee Stock Purchase Plan purchase
Exercise of pre-funded warrants
Issuance of common stock and pre-funded warrants, net of issuance costs $8,183
Exercise of common warrants
Restricted stock vested in the period
Exercise of stock options
Issuance of common stock, net of issuance costs of $1,528
|
2024-12-31 |
| 2024-11-14 | 10659.35 | 未披露 | 定期报告 | 2024-11-11 |
| 2024-11-14 | 10571.03 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Exercise of stock options
Restricted stock vested in the period
|
2024-09-30 |
| 2024-08-12 | 10565.40 | 未披露 | 定期报告 | 2024-08-08 |
| 2024-08-12 | 10564.64 | 未披露 | 定期报告 | 2024-07-31 |
| 2024-08-12 | 10553.97 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Exercise of stock options
Issuance of common stock per Employee Stock Purchase Plan purchase
Issuance of common stock, net of issuance costs of $480
Issuance of common stock and pre-funded warrants, net of issuance costs of $8,183
Exercise of pre-funded warrants
Exercise of common warrants
|
2024-06-30 |
| 2024-06-07 | 10541.40 | 未披露 |
更多>>
Common stock offered 13,001,120 shares by the company
|
2024-06-07 |
| 2024-05-13 | 9241.29 | 未披露 | 定期报告 | 2024-05-08 |
| 2024-04-25 | 9114.14 | 未披露 | 定期报告 | 2024-04-08 |
| 2024-05-13 | 9048.21 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Exercise of stock options
Issuance of common stock, net of issuance costs of $933
Exercise of pre-funded warrants
Restricted stock vested in the period
|
2024-03-31 |
| 2024-03-26 | 9002.56 | 未披露 | 定期报告 | 2024-03-21 |
| 2024-03-26 | 8839.34 | 未披露 | 定期报告 | 2024-03-01 |
| 2024-03-26 | 7836.91 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Restricted stock vested in the period
Exercise of pre-funded warrants
Issuance of common stock to related party, net of issuance costs of $525
Issuance of common stock and pre- funded warrants, net of issuance cost of $8,014
Stock option exercises
Issuance of common stock per Employee Stock Purchase Plan purchase
|
2023-12-31 |
| 2023-12-21 | 7827.40 | 未披露 |
更多>>
Common stock offered 25,035,000 shares by the company
|
2023-12-26 |
| 2023-08-07 | 5323.90 | 未披露 | 定期报告 | 2023-08-02 |
| 2023-08-07 | 5315.11 | 未披露 |
更多>>
From March 31,2023 to June 30,2023
Exercise of stock options
Issuance of common stock per Employee Stock Purchase Plan purchase
|
2023-06-30 |
| 2023-05-08 | 5308.39 | 未披露 | 定期报告 | 2023-05-01 |
| 2023-05-08 | 5308.07 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Exercise of stock options
Exercise of pre-funded warrants
Issuance of common stock to a related party, net of issuance costs of $525
Restricted stock vested in the period
|
2023-03-31 |
| 2023-03-06 | 5049.33 | 未披露 | 定期报告 | 2023-03-01 |
| 2023-03-06 | 4772.30 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Stock option exercises
Issuance of common stock per Employee Stock Purchase Plan purchase
Issuance of common stock, pre-funded warrants and common warrants, net of issuance costs of $7,988 (related party proceeds - $9,500)
Restricted common stock vested in the period
|
2022-12-31 |
| 2022-11-03 | 4763.04 | 未披露 | 定期报告 | 2022-10-28 |
| 2022-11-03 | 4762.65 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock, pre-funded warrants and common warrants, net of issuance costs (related party amount of $9,500)
Stock option exercises
|
2022-09-30 |
| 2022-08-08 | 4761.77 | 未披露 | 定期报告 | 2022-08-02 |
| 2022-07-08 | 4757.74 | 未披露 |
更多>>
In the private placement, Annexon is selling 9,013,834 shares of common stock,the private placement is expected to close on July 11, 2022, subject to the satisfaction of customary closing conditions.
|
2022-07-11 |
| 2022-08-08 | 3860.39 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock per Employee Stock Purchase Plan purchase
|
2022-06-30 |
| 2022-03-01 | 3856.36 | 未披露 | 定期报告 | 2022-02-25 |
| 2022-03-01 | 3856.09 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Stock option exercises
Issuance of common stock per ESPP purchase
|
2021-12-31 |
| 2021-11-09 | 3837.48 | 未披露 | 定期报告 | 2021-10-29 |
| 2021-11-09 | 3837.01 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Stock option exercises
|
2021-09-30 |
| 2021-08-16 | 3833.23 | 未披露 | 定期报告 | 2021-07-31 |
| 2021-08-16 | 3832.21 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Stock option exercises
Issuance of common stock per ESPP purchase
|
2021-06-30 |
| 2021-05-17 | 3825.87 | 未披露 | 定期报告 | 2021-04-30 |
| 2021-04-22 | 3824.02 | 未披露 | 定期报告 | 2021-04-05 |
| 2021-05-17 | 3823.25 | 未披露 | 定期报告 | 2021-03-31 |
| 2021-03-25 | 3815.76 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of Series D redeemable convertible preferred stock, net of issuance costs of $5,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Issuance of common stock in connection with initial public offering, net of issuance costs of $24,700
Stock option exercises
|
2020-12-31 |
| 2020-11-16 | 3815.76 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Issuance of common stock in connection with initial public offering, net of issuance costs of $24.7 million
Stock option exercises
|
2020-09-30 |
| 2020-09-08 | 3814.81 | 未披露 | 定期报告 | 2020-08-31 |
| 2020-07-24 | 3600.87 | 未披露 |
更多>>
1.Common stock offered by the company 14,750,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 13,117,963 shares of common stock as of March 31, 2020.
|
2020-07-24 |
1.Common Stock offered 25,096,153 shares by the company
2.The underwriter exercised the option in full to purchase 3,750,000 shares of common stock
From June 30, 2025 to September 30, 2025
Issuance of common stock, net of issuance costs of $697
Restricted stock vested in the period
Exercise of stock options
From March 31, 2025 to June 30, 2025
Issuance of common stock per Employee Stock Purchase Plan purchase
From December 31, 2024 to March 31, 2025
Exercise of stock options
Restricted stock vested in the period
From December 31, 2023 to December 31, 2024
Issuance of common stock per Employee Stock Purchase Plan purchase
Exercise of pre-funded warrants
Issuance of common stock and pre-funded warrants, net of issuance costs $8,183
Exercise of common warrants
Restricted stock vested in the period
Exercise of stock options
Issuance of common stock, net of issuance costs of $1,528
From June 30, 2024 to September 30, 2024
Exercise of stock options
Restricted stock vested in the period
From March 31, 2024 to June 30, 2024
Exercise of stock options
Issuance of common stock per Employee Stock Purchase Plan purchase
Issuance of common stock, net of issuance costs of $480
Issuance of common stock and pre-funded warrants, net of issuance costs of $8,183
Exercise of pre-funded warrants
Exercise of common warrants
Common stock offered 13,001,120 shares by the company
From December 31, 2023 to March 31, 2024
Exercise of stock options
Issuance of common stock, net of issuance costs of $933
Exercise of pre-funded warrants
Restricted stock vested in the period
From December 31, 2022 to December 31, 2023
Restricted stock vested in the period
Exercise of pre-funded warrants
Issuance of common stock to related party, net of issuance costs of $525
Issuance of common stock and pre- funded warrants, net of issuance cost of $8,014
Stock option exercises
Issuance of common stock per Employee Stock Purchase Plan purchase
Common stock offered 25,035,000 shares by the company
From March 31,2023 to June 30,2023
Exercise of stock options
Issuance of common stock per Employee Stock Purchase Plan purchase
From December 31, 2022 to March 31, 2023
Exercise of stock options
Exercise of pre-funded warrants
Issuance of common stock to a related party, net of issuance costs of $525
Restricted stock vested in the period
From December 31, 2021 to December 31, 2022
Stock option exercises
Issuance of common stock per Employee Stock Purchase Plan purchase
Issuance of common stock, pre-funded warrants and common warrants, net of issuance costs of $7,988 (related party proceeds - $9,500)
Restricted common stock vested in the period
From June 30, 2022 to September 30, 2022
Issuance of common stock, pre-funded warrants and common warrants, net of issuance costs (related party amount of $9,500)
Stock option exercises
In the private placement, Annexon is selling 9,013,834 shares of common stock,the private placement is expected to close on July 11, 2022, subject to the satisfaction of customary closing conditions.
From March 31, 2022 to June 30, 2022
Issuance of common stock per Employee Stock Purchase Plan purchase
From December 31, 2020 to December 31, 2021
Stock option exercises
Issuance of common stock per ESPP purchase
From June 30, 2021 to September 30, 2021
Stock option exercises
From March 31, 2021 to June 30, 2021
Stock option exercises
Issuance of common stock per ESPP purchase
from December 31, 2019 to December 31, 2020
Issuance of Series D redeemable convertible preferred stock, net of issuance costs of $5,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Issuance of common stock in connection with initial public offering, net of issuance costs of $24,700
Stock option exercises
From June 30, 2020 to September 30, 2020
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Issuance of common stock in connection with initial public offering, net of issuance costs of $24.7 million
Stock option exercises
1.Common stock offered by the company 14,750,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 13,117,963 shares of common stock as of March 31, 2020.